Stat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1

Area of Science:

• Oncology
• Cell Biology
• Molecular Medicine

Background:

• Cancer cells often exhibit amplified centrosomes, necessitating their clustering for bipolar mitotic spindle formation.
• Targeting centrosome clustering is an emerging therapeutic strategy in cancer treatment.

Purpose of the Study:

• To identify inhibitors of centrosome clustering.
• To elucidate the mechanism of Stat3-mediated centrosome clustering and its therapeutic implications.

Main Methods:

• High-content chemical screening to identify centrosome clustering inhibitors.
• Utilizing Stat3 depletion and inhibition in cancer cell lines and in vivo tumor models.
• Investigating the interaction between Stat3, Stathmin, and PLK1.

Main Results:

• Stattic, a Stat3 inhibitor, was identified as an inhibitor of centrosome clustering.
• Stat3 inhibition significantly impaired centrosome clustering and cancer cell viability.
• A transcription-independent mechanism for Stat3-mediated centrosome clustering involving Stathmin and PLK1 was described.
• Breast tumor cells with PLK4-driven centrosome amplification showed sensitivity to Stat3 inhibitors.

Conclusions:

• Stat3 plays an unexpected but critical role in regulating centrosome clustering.
• Stat3 inhibitors may be effective in treating tumors characterized by centrosome amplification and Stat3-dependent clustering.